↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$819KSold on the market
1Companies
Aug 25, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 202617:27 | Aug 25, 2026from Aug 21, 2026 | PGENPRECIGEN, INC. | Chief Operating Officer | S · Sell10b5-1 | $7.50 | −50,000 | 468,865 | -10% | −$375K | ||
| Aug 25, 202617:27 | Aug 25, 2026from Aug 21, 2026 | PGENPRECIGEN, INC. | Chief Operating Officer | M · Exercise10b5-1 | $2.03 | +57,500 | 484,207 | +13% | $117K | ||
| Aug 25, 202617:27 | Aug 23, 2026 | PGENPRECIGEN, INC. | Chief Operating Officer | F · Tax10b5-1 | $7.20 | −3,647 | 468,865 | -1% | $26K | ||
| Aug 7, 202617:04 | Aug 6, 2026 | PGENPRECIGEN, INC. | Chief Operating Officer | S · Sell10b5-1 | $6.86 | −32,739 | 465,012 | -7% | −$225K | ||
| Aug 3, 202618:12 | Aug 3, 2026 | PGENPRECIGEN, INC. | Chief Operating Officer | S · Sell10b5-1 | $6.50 | −33,772 | 497,751 | -6% | −$220K | ||
| Aug 3, 202618:12 | Aug 3, 2026 | PGENPRECIGEN, INC. | Chief Operating Officer | M · Exercise10b5-1 | $2.33 | +33,772 | 531,523 | +7% | $79K |